We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
VanEck India Growth Leaders ETF
GLIN
$93.2M
| $41K | ﹤0.01% |
+1,000
| New | +$41.1K |
|
2227
Insmed
INSM
$28.6B
| $41K | ﹤0.01% |
1,500
+1,466
| +4,312% | +$38.5K |
|
2228
Lantheus
LNTH
$6.59B
| $41K | ﹤0.01% |
1,615
| – | – |
|
2229
Main Street Capital
MAIN
$5.48B
| $41K | ﹤0.01% |
1,014
+353
| +53% | +$14.7K |
|
2230
Matsons
MATX
$6.18B
| $41K | ﹤0.01% |
514
-501
| -49% | -$37.1K |
|
2231
Nexstar Media Group
NXST
$5.97B
| $41K | ﹤0.01% |
275
-127
| -32% | -$18.7K |
|
2232
Global X US Preferred ETF
PFFD
$2.16B
| $41K | ﹤0.01% |
1,622
| – | – |
|
2233
uniQure
QURE
$3.22B
| $41K | ﹤0.01% |
+1,300
| New | +$39.6K |
|
2234
SouthState Bank Corp
SSB
$10.5B
| $41K | ﹤0.01% |
557
| – | – |
|
2235
Invesco Municipal Opportunity Trust
VMO
$663M
| $41K | ﹤0.01% |
3,010
| – | – |
|
2236
Barron's 400 ETF
BFOR
$236M
| $40K | ﹤0.01% |
2,728
+1,528
| +127% | +$22.9K |
|
2237
FIVE9
FIVN
$2.54B
| $40K | ﹤0.01% |
253
+3
| +1% | +$547 |
|
2238
Hexcel
HXL
$7.82B
| $40K | ﹤0.01% |
683
+384
| +128% | +$22.1K |
|
2239
Invesco KBW Bank ETF
KBWB
$6.73B
| $40K | ﹤0.01% |
605
+1
| +0.2% | +$65 |
|
2240
MeiraGTx Holdings
MGTX
$1.21B
| $40K | ﹤0.01% |
3,100
+3,000
| +3,000% | +$41.1K |
|
2241
Nuveen ESG US Aggregate Bond ETF
NUBD
$466M
| $40K | ﹤0.01% |
+1,550
| New | +$40.6K |
|
2242
Radian Group
RDN
$4.93B
| $40K | ﹤0.01% |
1,795
+242
| +16% | +$5.49K |
|
2243
Skillsoft
SKIL
$81.6M
| $40K | ﹤0.01% |
175
-125
| -42% | -$24.3K |
|
2244
US Commodity Index
USCI
$365M
| $40K | ﹤0.01% |
1,000
| – | – |
|
2245
Zymeworks
ZYME
$1.67B
| $40K | ﹤0.01% |
1,387
| – | – |
|
2246
Corpay
CPAY
$25.7B
| $40K | ﹤0.01% |
155
-48
| -24% | -$12.4K |
|
|
TRTN
2247
DELISTED
Triton International Limited
TRTN
| $40K | ﹤0.01% |
769
+79
| +11% | +$4.1K |
|
|
BKI
2248
DELISTED
Black Knight, Inc. Common Stock
BKI
| $40K | ﹤0.01% |
564
+414
| +276% | +$31.8K |
|
|
VER
2249
DELISTED
VEREIT, Inc.
VER
| $40K | ﹤0.01% |
908
+450
| +98% | +$21.9K |
|
2250
Boyd Gaming
BYD
$6.06B
| $39K | ﹤0.01% |
629
| – | – |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.